Dublin

Sale of 260 Acres at Dublin Airport presents unique real estate opportunity

Retrieved on: 
Wednesday, May 31, 2023
London, Dublin, Irish government response to the COVID-19 pandemic, Irish states since 1171, Ryanair, Dublin Port Tunnel, JLL, Airport, Multimedia, DAA, Government, Sale, DA, Aer Lingus, COVID-19, Fingal County Council, M50, Dublin Airport, Growth, Malaysia National Aviation Policy, Policy, Airline, Transport

DUBLIN, May 31, 2023 /PRNewswire/ -- A major landbank between the runways at Dublin Airport in north County Dublin, Ireland is this week being placed on the market by JLL. The lands are privately held by the long-term owners. The infrastructural land which is available for sale by private treaty in its entirety or in three separate lots, totals approximately 260 acres.

Key Points: 
  • DUBLIN, May 31, 2023 /PRNewswire/ -- A major landbank between the runways at Dublin Airport in north County Dublin, Ireland is this week being placed on the market by JLL.
  • The infrastructural land which is available for sale by private treaty in its entirety or in three separate lots, totals approximately 260 acres.
  • DAA, a commercial company wholly-owned by the Irish State, owns and operates Dublin Airport.
  • The lands are zoned DA – Dublin Airport, in the 2023 to 2029 Development Plan for the local authority, Fingal County Council.

Sale of 260 Acres at Dublin Airport presents unique real estate opportunity

Retrieved on: 
Wednesday, May 31, 2023
London, Dublin, Irish government response to the COVID-19 pandemic, Irish states since 1171, Ryanair, Dublin Port Tunnel, JLL, Airport, DAA, Government, Sale, DA, Aer Lingus, COVID-19, Fingal County Council, M50, Dublin Airport, Growth, Malaysia National Aviation Policy, Policy, Airline, Transport

DUBLIN, May 31, 2023 /PRNewswire/ -- A major landbank between the runways at Dublin Airport in north County Dublin, Ireland is this week being placed on the market by JLL. The lands are privately held by the long-term owners. The infrastructural land which is available for sale by private treaty in its entirety or in three separate lots, totals approximately 260 acres.

Key Points: 
  • DUBLIN, May 31, 2023 /PRNewswire/ -- A major landbank between the runways at Dublin Airport in north County Dublin, Ireland is this week being placed on the market by JLL.
  • The infrastructural land which is available for sale by private treaty in its entirety or in three separate lots, totals approximately 260 acres.
  • DAA, a commercial company wholly-owned by the Irish State, owns and operates Dublin Airport.
  • The lands are zoned DA – Dublin Airport, in the 2023 to 2029 Development Plan for the local authority, Fingal County Council.

Verena at Hilliard Independent Senior Living Celebrates Grand Opening in Hilliard, Ohio

Retrieved on: 
Wednesday, June 15, 2022
Dublin, House, Multimedia, Columbus Metropolitan Library, Commerce, Dublin Chamber of Commerce, Ohio House of Representatives, Senate, Interior design

HILLIARD, Ohio, June 15, 2022 /PRNewswire/ --Verena at Hilliard, a newly developed luxury 55+ Independent Senior Living Community operated by True Connection Communities, hosted a grand opening celebration and ribbon cutting ceremony on June 8, 2022.

Key Points: 
  • HILLIARD, Ohio, June 15, 2022 /PRNewswire/ --Verena at Hilliard, a newly developed luxury 55+ Independent Senior Living Community operated by True Connection Communities, hosted a grand opening celebration and ribbon cutting ceremony on June 8, 2022.
  • Ohio State Representative and House Minority Leader C. Allison Russo, Ohio Senate President Matt Huffman, Ohio Senator Stephanie Kunze, the Hilliard Area Chamber of Commerce, and the Dublin Chamber of Commerce joined Verena at Hilliard and True Connection Communities leadership in the celebration.
  • "Verena at Hilliard offers seniors and their family members a great lifestyle experience, including direct indoor access to the Hilliard library."
  • Verena at Hilliard is a premier 55+ Independent Senior Living Community in Hilliard, Ohio, featuring one- and two-bedroom luxury residences.

Ravendex Readies for p2pb2b.io Exchange Listing Ahead of Its Staking Protocol Release

Retrieved on: 
Friday, December 10, 2021
Cardano, Treasury, Prefix delegation, Uniswap, Blockchain, ISPO, ADA, RAVE, Rave, UNI, Cryptocurrency

As regards liquidity, Ravendex will utilize the Cardano $ADA Staking Pool rewards system.

Key Points: 
  • As regards liquidity, Ravendex will utilize the Cardano $ADA Staking Pool rewards system.
  • Token owners can earn incentives by delegating their tokens to the staking pool instead of keeping them locked up in a protocol or pool that they can't access.
  • Ravendex staking rewards are given with a three-epoch lag after the pool goes live for three epochs.
  • So far, Ravendex has offered to issue a limited number of 1,000,000,000 $RAVE.

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

Retrieved on: 
Monday, December 6, 2021
Research, Patient, GHRS, MADRS, TRD, Nasdaq, G&A, GLOBE, Lists of diseases, Depression, Psychiatry, Pharmaceutical industry

DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the third quarter ended September 30, 2021 and gave updates on its business.

Key Points: 
  • DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the third quarter ended September 30, 2021 and gave updates on its business.
  • R&D expenses were $2.6 million for the quarter ended September 30, 2021, compared to $55 thousand for the same quarter in 2020.
  • G&A expenses were $2.1 million for the quarter ended September 30, 2021, compared to $5 thousand for the same quarter in 2020.
  • Net loss was $1.8 million, or $0.035 loss per share, for the quarter ended September 30, 2021, compared to $60 thousand, or $0.002 loss per share, for the same quarter in 2020.

GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression

Retrieved on: 
Monday, December 6, 2021
Research, Patient, GHRS, MADRS, TRD, Nasdaq, GLOBE, Lists of diseases, Depression, Psychiatry, Pharmaceutical industry

The Phase 2 part of the clinical trial recruited 8 patients.

Key Points: 
  • The Phase 2 part of the clinical trial recruited 8 patients.
  • Patients followed a proprietary GH001 individualized dosing regimen administered on a single day with up to three increasing doses of GH001 (6 mg, 12 mg and 18 mg).
  • Based on this trial design, 6 patients received 6 mg and 12 mg doses of GH001 and 2 patients received 6 mg, 12 mg and 18 mg doses of GH001.
  • With GH001, we have completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD).

Ravendex - Next Gen Non-Custodial DEX on Cardano Blockchain and Launchpad Powered by Cardano Blockchain

Retrieved on: 
Sunday, December 5, 2021
Cardano, Ethereum, RAVE, Launch pad, AAVE, DEX, Cardano (blockchain platform), Cryptocurrency

Dublin, Ireland--(Newsfile Corp. - December 5, 2021) - Ravendex primarily ranks to be the first non-custodial decentralized exchange and Launchpad powered by the Cardano Blockchain.

Key Points: 
  • Dublin, Ireland--(Newsfile Corp. - December 5, 2021) - Ravendex primarily ranks to be the first non-custodial decentralized exchange and Launchpad powered by the Cardano Blockchain.
  • Due to Cardano Blockchains speed and low transaction costs, the utilization of borrowed funds and overall returns to investors were greater and more efficient than other networks.
  • Soon, the much-anticipated decentralized automated market maker system, RavenDex, will be available for trading.
  • As revealed by Ravendex, $RAVE holders may stake their tokens to receive $RAVE rewards via a simple web interface.

Cardano Based-Ravendex to Hold First Internal AMA on 30th November

Retrieved on: 
Tuesday, November 30, 2021
Cardano, Ethereum, AMA, ADA, RAVE, DEX, Cardano (blockchain platform), AAVE, First International Bank of Grenada, APY, Cryptocurrency

Dublin, Ireland--(Newsfile Corp. - November 30, 2021) - Ravendex is pleased to inform the community regarding its FIRST Internal AMA on 30th November.

Key Points: 
  • Dublin, Ireland--(Newsfile Corp. - November 30, 2021) - Ravendex is pleased to inform the community regarding its FIRST Internal AMA on 30th November.
  • Ravendex allows non-custodial decentralized asset and liquidity swaps between native Cardano tokens and ADA for the first time on the Cardano Blockchain.
  • With its unique features like distributing shared liquidity across numerous assets on the Cardano ecosystem, it is a cross-chain exchange.
  • There will be a first internal AMA on November 30th, followed by an external AMA on Cardanodaily.

Innovation Zed Announce 2022 Launch of InsulCheck DOSE Add-on Technology for Insulin Pens

Retrieved on: 
Monday, November 15, 2021
OLED, Innovation, Lilly, University College Dublin, Lithium, Ecosystem, Caregiver, Method, CEO, BLE, Technology, Freedom, CE, Bluetooth Low Energy, Bluetooth Special Interest Group, Growth, MDI, Intention, Over-the-air programming, Insulin, GLOBE, Novo Nordisk, HMO, Temperature, FOTA, Time, Name, Patient, FDA, Pharmaceutical industry, Aquaculture, Medical imaging, Video game console

"It is with great excitement that we announce the arrival of our InsulCheck DOSE by Innovation Zed.

Key Points: 
  • "It is with great excitement that we announce the arrival of our InsulCheck DOSE by Innovation Zed.
  • This is the reason we at Innovation Zed took an incremental approach to developing the InsulCheck DOSE product."
  • Innovation Zed has collaborated with SHL Medical in the development of InsulCheck DOSE.
  • InsulCheck DOSE is a single unit add-on device for pen injectors that automatically captures dose value dialled, injection event time stamp, temperature andmounting/unmounting events.

SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant

Retrieved on: 
Wednesday, November 10, 2021
GMP, COO, Herbal medicine, European Commission, CEO, Cannabinoid, Goal, Research, Policy, Partnership, GLOBE, Company, Royal commission, Pharmaceutical industry

LISBON, Portugal, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOMA Pharmaceuticals Unipessoal LDA has received an innovative products grant of 2.7 million euros by the Portugal 2020 committee.

Key Points: 
  • LISBON, Portugal, Nov. 10, 2021 (GLOBE NEWSWIRE) -- SOMA Pharmaceuticals Unipessoal LDA has received an innovative products grant of 2.7 million euros by the Portugal 2020 committee.
  • Being recognized by the PT 2020 assessors is an honor, which highlights the meticulous planning that goes into developing innovative cannabis medicines for the EU market, said Michael Sassano, CEO and Chairman of Somai Pharmaceuticals.
  • Portugal 2020 is a partnership agreement between Portugal and the European Commission to fund programming that helps meet national and continental economic, social, and territorial policy goals that align with sustainability and inclusivity.
  • SOMA Pharmaceuticals is an international company focused on extraction of the cannabis plant and the manufacturing of pharmaceutical formulations for the EU market.